CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
UCB Sa Company Snapshot
UCB Sa operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other pharmaceutical manufacturers in Europe: Biomerieux SA of FRANCE (2020 sales of 3.12 billion Euros [US$3.79 billion] ), Ipsen SA of FRANCE (2.69 billion Euros [US$3.27 billion] ), and Lonza Group AG which is based in SWITZERLAND (4.51 billion Swiss Francs [US$4.97 billion] ).

Sales Analysis. UCB Sa reported sales of 5.35 billion Euro (US$6.50 billion) for the year ending December of 2020. This represents an increase of 8.8% versus 2019, when the company's sales were 4.91 billion Euro. Sales at UCB Sa have increased during each of the previous five years (and since 2015, sales have increased a total of 38%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
UCB Sa
  Stock Performance Chart for UCB Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (2/19/2021): 83.62
(Figures in Euros )
1 Week -4.7%   13 Weeks -4.5%  
4 Weeks -8.9%   52 Weeks -9.0%  
 
UCB Sa Key Data:
  Ticker: UCB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 5,347,000,000
(Year Ending Jan 2021).
Employees: 7,606
  Currency: Euros Market Cap: 15,814,163,559
  Fiscal Yr Ends: December Shares Outstanding: 189,119,392
  Share Type: Actions Ordinaires Closely Held Shares: 68,076,980
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.